Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 3Other hematologic neoplasm 1Lymphoid 1Head & Neck 1CNS 1Breast 1

Conditions

Lung Neoplasms 3Radiation Pneumonitis 1Postoperative Complications 1Breast Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Respiratory Function Tests × Thoracic × Clear all
NCT06925295 2026-01-02

(XeRTLC)

University of Iowa

Phase 2 Recruiting
15 enrolled
Thoracic

Lung Neoplasms

NCT02735746 2025-08-22

HFFLI

Cedars-Sinai Medical Center

Completed
60 enrolled
BreastThoracic

Breast Neoplasms, Lung Neoplasms, Radiation Pneumonitis

NCT06338007 2024-04-17

Relationship Between Hand Dynamometer Measurements, PFT, and mFI With Postoperative Outcomes

Atatürk Chest Diseases and Chest Surgery Training and Research Hospital

Unknown
100 enrolled
Thoracic

Lung Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡